Protection against muscle damage in competitive sports players: The effect of the immunomodulator AM3

Journal of Sports Sciences

Volumn 22, Issue 9, 2004, Pages 827-833

  Córdova Martínez, Alfredo ^a,d   Martin, J Francisco ^a   Reyes, Eduardo ^b,c   Alvarez Mon, Melchor ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c Industrial Farmaceutica Cantabria SA   (Spain)

^d EU de Fisioterapia   (Spain)

Author keywords

AM3; Creatine phosphokinase; Exercise; Muscle damage; Myoglobin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; CREATININE; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOFERON; IMMUNOMODULATING AGENT; LACTATE DEHYDROGENASE; MYOGLOBIN; PLACEBO; UREA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHLETE; BIOCHEMISTRY; BODY HEIGHT; BODY MASS; CELLULAR IMMUNITY; CLINICAL TRIAL; COMPETITION; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; EXERCISE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE CONTRACTION; MUSCLE INJURY; OXYGEN CONSUMPTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SPAIN; SPORT INJURY; VOLUNTEER;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; ATHLETIC INJURIES; CALCIUM PHOSPHATES; COMPETITIVE BEHAVIOR; CREATINE KINASE; DOUBLE-BLIND METHOD; EXTREMITIES; GLYCOPEPTIDES; HUMANS; HYDRO-LYASES; IMMUNOLOGIC FACTORS; MALE; MUSCLES; MYOGLOBIN; PILOT PROJECTS;

EID: 5044224202     PISSN: 02640414     EISSN: None     Source Type: Journal    
DOI: 10.1080/02640410410001716742     Document Type: Article

References (31)

1. Abalnave, C.D. and Thompson, M.W. (1993). Effect of training on eccentric exercise-induced muscle damage. Journal of Applied of Physiology, 75, 1545-1551.
2. Almekinders, L.C. (1999). Anti-inflammatory treatment of muscular injuries in sport. Sports Medicine, 28, 383-388.
3. Apple, F.S., Rogers, M.A., Casal, D.C., Sherman, W.M. and Ivy, J.L. (1985). Creatine kinase-MB isoenzyme adaptations in stressed human skeletal muscle of marathon runners. Journal of Applied Physiology, 59, 149-153.
4. Armstrong, R.B. (1986). Muscle damage and endurance events. Sports Medicine, 3, 370-381.
5. Armstrong, R.B. (1990). Initial events in exercise-induced muscular injury. Medicine and Science in Sports and Exercise, 22, 429-434.
6. Bourgeois, J., MacDougall, D., MacDonald, J. and Tarnopolsky, M. (1999). Naproxen does not alter indices of damage in resistance-exercise trained men. Medicine and Science in Sports and Exercise, 31, 4-9.
7. Byrne, C. and Eston, R. (2002a). The effect of exercise-induced muscle damage on isometric and dynamic knee extensor strength and vertical jump performance. Journal of Sports Sciences, 20, 417-425.
8. Byrne, C. and Eston, R. (2002b). Maximal-intensity isometric and dynamic exercise performance after eccentric muscle actions. Journal of Sports Sciences, 20, 951-959.
9. Clarkson, P.M., Nosaka, D. and Braun, D. (1992). Muscle function after exercise-induced muscle damage and rapid adaptation. Medicine and Science in Sports and Exercise, 24, 512-520.
10. Córdova, A. and Alvarez-Mon, M. (1995). Behavior of zinc in physical exercise: a special reference to immunity and fatigue. Neuroscience Biobehavioural Review, 19, 439-445.
11. Córdova, A. and Alvarez-Mon, M. (1999). Immune system: effect of immunomodulators in recovery of sportsmen. Archivos de Medicina del Deporte (Esp.), 70, 155-165 (in Spanish).
12. Friden, J. and Lieber, R.L. (1992). Structural and mechanical basis of exercise-induced muscle injury. Medicine and Science in Sports and Exercise, 24, 521-530.
13. Hasson, S.M., Daniels, J.C., Divine, J.G. et al. (1993). Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation. Medicine and Science in Sports and Exercise, 25, 9-17.
14. Howell, J.N., Chleboun, G. and Conatser, R. (1993). Muscle stiffness, strength loss, swelling and soreness following exercise-induced injury in humans. Journal of Physiology (Lond.), 464, 183-196.
15. Jacobs, S.C., Bootsma, A.L., Willems, P.W., Bar, P.R. and Wokke, J.H. (1996). Prednisone can protect against exercise-induced muscle damage. Journal of Neurology, 243, 410-416.
16. Kuipers, H. (1994). Exercise-induced muscle damage. International Journal of Sports Medicine, 15, 132-135.
17. Macintyre, D.L., Reid, W.D. and McKenzie, D.C. (1995). Delayed muscle soreness: the inflammatory response to muscle injury and its clinical implications. Sports Medicine, 20, 24-40.
18. Northoff, H. and Berg, A. (1991). Immunologic mediators as parameters of the reaction to strenuous exercise. International Journal of Sports Medicine, 12, S9-S15.
19. Nosaka, K. and Clarkson, P.M. (1996a). Variability in serum creatine kinase response after eccentric exercise of the elbow flexors. International Journal of Sports Medicine, 17, 120-127.
20. Nosaka, K. and Clarkson, P.M. (1996b). Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Medicine and Science in Sports and Exercise, 28, 953-961.
21. Pedersen, B.K., Ostrowski, K., Rohde, T. and Bruunsgaard, H. (1998). The cytokine response to strenuous exercise. Canadian Journal of Physiology and Pharmacology, 76, 505-511.
22. Perez-Garcia, R., Perez-Garcia, A., Verbeelen, D. et al. (2002). AM3 (Inmunoferon) as an adjuvant to hepatitis B vaccination in hemodialysis patients. Kidney International, 61, 1845-1852.
23. Prieto, A., Reyes, E., Bernstein, E.D. et al. (2001). Defective natural killer and phagocytic activities in COPD are restored by glycophosphopeptical (Inmunoferón®). American Journal of Respiratory and Critical Care Medicine, 163, 1578-1583.
24. Rhind, S.G., Shek, P.N. and Shephard, R.J. (1995). The impact of exercise on cytokines and receptor expression. Exercise and Immunology Review, 1, 97-148.
25. Rivier, A., Pene, J., Chanez, P. et al. (1994). Release of cytokines by blood monocytes during strenuous exercise. International Journal of Sports Medicine, 15, 192-198.
26. Rojo, J.M., Rejas, M.T., Ojeda, G., Portoles, P. and Barasoain, I. (1986). Enhancement of lymphocyte proliferation, interleukin-2 production and NK activity by Inmunoferón (AM-3), a fungal immunomodulator: variations in normal and immunosuppressed mice. International Journal of Immunopharmacology, 8, 593-597.
27. Smith, L.L. (1991). Acute inflammation: the underlying mechanism in delayed onset muscle soreness? Medicine and Science in Sports and Exercise, 23, 542-551.
28. Sorichter, S., Koller, A., Haid, D. et al. (1995). Light concentric exercise and heavy eccentric muscle loading: effects on CK, MRI and markers of inflammation. International Journal of Sports Medicine, 16, 288-292.
29. Sorichter, S., Fluschendorf, B. and Mair, J. (1999). Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exercise and Immunology Review, 5, 5-21.
30. Ullum, H., Haahr, R.M., Diamant, M. et al. (1994). Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. Journal of Applied Physiology, 77, 93-97.
31. Villarrubia, V.G., Moreno, M.C., Calvo, C., Gonzalez, S. and Alvarez-Mon, M. (1997). The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3. Immunopharmacology and Immunotoxicology, 19, 53-74.